ranolazine 500 MG Oral Granules

RxCUI: 2594760
RxNorm name: ranolazine 500 MG Oral Granules
Display name: ranolazine 500 MG Oral Granules
Full name: ranolazine 500 MG Oral Granules
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ASPRUZYO SPRINKLE	RANOLAZINE	SUN PHARMACEUTICAL INDUSTRIES, INC.	dd9f81e4-50da-4551-aed5-559d304df42e	2025-01-29	Warnings, Adverse reactions	Exact identifier rxcui: 2594760

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
dd9f81e4-50da-4551-aed5-559d304df42e	ranolazine 500 MG Oral Granules [PSN] · ranolazine 500 MG Oral Granules [SCD]	2	3	These highlights do not include all the information needed to use ASPRUZYO SPRINKLE safely and effectively. See full prescribing information for ASPRUZYO SPRINKLE. ASPRUZYO SPRINKLE TM (ranolazine) extended-release granules, for oral use Initial U.S. Approval: 2006	20250129